A dendritic cell-based vaccine elicits T cell responses associated with control of HIV-1 replication.
García F, Climent N, Guardo AC, Gil C, León A, Autran B, Lifson JD, Martínez-Picado J, Dalmau J, Clotet B, Gatell JM, Plana M, Gallart T; DCV2/MANON07-ORVACS Study Group.
García F, et al. Among authors: leon a.
Sci Transl Med. 2013 Jan 2;5(166):166ra2. doi: 10.1126/scitranslmed.3004682.
Sci Transl Med. 2013.
PMID: 23283367
Clinical Trial.